Effects of protein energy supplementation during pregnancy on fetal growth
Citation: Liberato S.C., Singh G., Mulholland K. Effects of protein energy supplementation during pregnancy on fetal growth: a review of the literature focusing on contextual factors. Food & Nutrition Research, 2013;57(1):1-14
Balanced protein energy supplementation given to pregnant women with energy or protein deficit appears to improve fetal growth, increase birth weight and height, and decrease the percentage of low birth weight. Supplements with excess protein provided to women with a diet already containing adequate protein may conversely impair fetal growth. There is also no consensus on the best time to start supplementation. Strong quality studies examining adequate criteria to screen women who would benefit from supplementation, time to start supplementation, and type of supplements are warranted.
Diet during pregnancy is an important factor in assuring adequate fetal growth. Studies have been conducted to assess the effects of Protein Energy Supplementation (PES) during pregnancy on fetal growth. This paper aimed to review such studies, however no effective method for selecting women eligible for trial was identified. Twenty studies were analyzed (11 randomized control trials, 8 controlled before and after and 1 proposed trail). It was found that PES showed improved fetal growth, increased birth weight and height, as well as a decrease in percentage of infants with low birth weight. Supplements provided to women with adequate protein diets may adversely affect fetal growth. No conclusion on the best time to start PES was reached.
Disclaimer: This summary has been written by staff and volunteers of Evidence Aid in order to make the content of the original document accessible to decision makers who are searching for the available evidence the prevention and treatment of malnutrition but may not have the time, initially, to read the original report in full. This summary is not intended as a substitute for the medical advice of physicians, other health workers, professional associations, guideline developers, or national governments and international agencies. If readers of this summary think that the evidence that is presented within it is relevant to their decision-making they should refer to the content and details of the original article, and the advice and guidelines offered by other sources of expertise, before making decisions. Evidence Aid cannot be held responsible for any decisions made about prevention or treatment of malnutirition on the basis of this summary alone.
If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.